NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (OTCBB:NEOI), the first company to specialize in the collection, processing and long term storage of stem cells from healthy adults for personal use in times of critical medical need, today announces its common stock and units have been approved to be listed on the American Stock Exchange under the ticker symbols—NBS and NBS.U—and will start trading August 9, 2007. The listing followed the completion of a public-offering in excess of $5 million and a one-for-ten reverse stock split.
